Big pharm giant Novartis has agreed to pay the federal government and 10 states a total of $72.5 million to settle a false claims lawsuit that was pending in San Francisco.
According to SF Appeal, the three-year-old lawsuit stemmed from a statement made by 3 former employees of Chiron Corp., which was acquired by Novartis prior to the whistle-blowing.
The lawsuit accused Novartis of submitting false bills to government health care programs for unauthorized (or "off-label") use of certain drugs.
California and nine other states will divide $29 million of the settlement between them. It's unknown how much California will receive.
Novartis confirmed the settlement, but did not admit any wrongdoing.